β-cell adaptation/dysfunction in an animal model of dyslipidemia and insulin resistance induced by the chronic administration of a sucrose-rich diet

Islets

Volumn 2, Issue 6, 2010, Pages 367-373

  Ferreira, Maria Del Rosario ^a   Lombardo, Yolanda B ^a   Chicco, Adriana ^a  

^a UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

Author keywords

cell; Dyslipidemia; Glucolipotoxicity; Sucrose rich diet

Indexed keywords

FATTY ACID; GLUCOKINASE; GLUCOSE; HEXOKINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PYRUVATE DEHYDROGENASE KINASE 2; STEROID 5ALPHA REDUCTASE 1; SUCROSE; TRIACYLGLYCEROL; UNCOUPLING PROTEIN 2;

ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DYSLIPIDEMIA; ENZYME ACTIVITY; FEEDING; FOOD INTAKE; INSULIN RELEASE; INSULIN RESISTANCE; MALE; MOUSE; NONHUMAN; OXIDATION; PANCREAS ISLET BETA CELL; PROTEIN CONTENT; PROTEIN EXPRESSION; SUGAR INTAKE;

ANIMALS; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; GLUCOKINASE; HEXOKINASE; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; ION CHANNELS; ISLETS OF LANGERHANS; MALE; MITOCHONDRIAL PROTEINS; PPAR GAMMA; PYRUVATE DEHYDROGENASE COMPLEX; RANDOM ALLOCATION; RATS; RATS, WISTAR; TIME FACTORS; TRIGLYCERIDES;

EID: 78751556250     PISSN: 19382014     EISSN: 19382022     Source Type: Journal    
DOI: 10.4161/isl.2.6.13869     Document Type: Article

References (38)

1. Nolan CJ, Prentki M. The islet β-cell: fuel responsive and vulnerable. Trends in Endocrinology and Metabolism 2008; 19:285-91.
2. Chan CB, Saleh MC, Koshkin V, Wheeler MB. Uncoupling protein 2 and islet function. Diabetes 2004; 53:136-42.
3. Poitout V. β-cell lipotoxicity: Burning fat into heat? Endocrinology 2004; 145:3563-5.
4. Briaud I, Harmon JS, Kelpe CL, Segu VBG, Poitout V. Lipotoxicity of the pancreatic β-cell is associated with glucose-dependent esterification of fatty acid into neutral lipids. Diabetes 2001; 50:315-23. (Pubitemid 32127288)
5. Lewis GF, Carpentier A, Khospow A, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocrine Review 2002; 23:201-29. (Pubitemid 34299024)
6. Unger RH, Orci L. Diseases of liporegulation: New perspective on obesity and related disorders. FASEB J 2001; 15:312-21.
7. Lombardo YB, Chicco A. Effects of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A Review. J Nutr Biochem 2006; 17:1-13.
8. Chicco A, D'Alessandro ME, Karabatas L, Pastorale C, Basabe JC, Lombardo YB. Muscle lipid metabolism and insulin secretion are altered in insulin-resistant rats fed a high sucrose diet. J Nutr 2003; 133:127-33.
9. Chen NG, Reaven GM. Fatty acid inhibition of glucose stimulated insulin secretion is enhanced in pancreatic islets from insulin-resistant rats. Metabolism 1999; 48:1314-7.
10. Maiztegui B, Borelli MI, Raschia MA, Del Zotto H, Gagliardino JJ. Islet adaptative changes to fructose- induced insulin resistance: β-cell mass, glucokinase, glucose metabolism and insulin secretion. J of Endocrinol 2009; 200:139-49.
11. Pighin D, Karabatas L, Rossi A, Chicco A, Basabe JC, Lombardo YB. Fish oil affects pancreatic fat storage, pyruvate dehydrogenase complex activity and insulin secretion in rats fed a sucrose-rich diet. J Nutrition 2003; 133:4095-101.
12. Randle PJ. Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years. Diabetes Metab Rev 1998; 14:363-83.
13. Zhou YP, Berggren PO, Grill V. A fatty acid-induced decrease in pyruvate dehydrogenase activity is an important determinant of β-cell dysfunction in the obese diabetic db/db mouse. Diabetes 1996; 45:580-6.
14. Gutman RA, Basilico MZ, Bernal C, Chicco A, Lombardo YB. Long-term hypertriglyceridemia and glucose intolerance in rats fed chronically an isocaloric sucrose-rich diet. Metabolism 1987; 36:1013-20.
15. Lombardo YB, Drago S, Chicco A, Fainstein-Day P, Gutman R, Gagliardino JJ, et al. Long term administration of a sucrose-rich diet to normal rats: relationship between metabolic and hormonal profiles and morphological changes in the endocrine pancreas. Metabolism 1996; 46:1527-32.
16. Prentki M, Nolan CJ. Islet β-cell failure in type 2 diabetes. J Clin Invest 2006; 116:1802-12. (Pubitemid 44033300)
17. Matschinsky FM. Banting Lecture 1995: A lesson in metabolic regulation inspired by glucokinase sensor paradigm. Diabetes 1996; 45:223-41.
18. Chen C, Hosokawa H, Bumbalo LM, Leahy JC. Mechanism of compensatory hyperinsulinemia in normoglycemic insulin-resistant spontaneously hypertensive rats. Augmented enzymatic activity of glucokinase in β-cells. J Clin Invest 1994; 94:399-404.
19. Chen C, Bumbalo L, Leahy JC. Increased activity of glucokinase in isolated islets from hyperinsulinemic rats. Diabetes 1994; 43:684-9. (Pubitemid 24138782)
20. Chan CB. Glucokinase activity in isolated islets from obese fa/fa Zucker rats. Biochem J 1993; 295:673-7.
21. Terauchi Y, Takamoto I, Kubota N, Matsui J, Suzuki R, Komeda K, et al. Glucokinase and IRS-2 are required for compensatory β cell hyperplasia in response to high-fat diet-induced insulin resistance. J Clin Invest 2007; 117:246-57.
22. Fridlyand LE, Philipson LH. Glucose sensing in the pancreatic beta cell: a computational systems analysis. Theoretical Biology and Medical Modelling 2010; 7:15-59.
23. Kim H, Ahn Y. Role of peroxisomal proliferator-activated receptor gamma in the glucose-sensing apparatus of liver and β-cells. Diabetes 2004; 60-5.
24. Nolan CJ, Madiraju MSRE, Delghingaro-Augusto V, Peyot ML, Prentki M. Fatty acid signaling in the β-cell and insulin secretion. Diabetes 2006; 55:16-23.
25. Poitout V, Robertson RP. Minireview: Secondary β-cell failure in type 2 diabetes. A consequence of glucotoxicity and lipotoxicity. Endocrinology 2002; 143:339-42.
26. Kooptiwut S, Kebede M, Zraika S, Visioni S, Aston-Mourney K, Favaloro J, et al. High glucose-induced impairment in insulin secretion is associated with reduction in islet glucokinase in a mouse model of susceptibility to islet dysfunction. J Mol Endocrinol 2005; 35:39-48.
27. Patane G, Piro S, Rabuazzo AM, Anello M, Vigneri B, Purello F. Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta-cells. Diabetes 2000; 49:735-40.
28. Prentki M, Joly E, El Assad W, Roduit R. Malonyl- CoA signaling, lipid partitioning and glucolipotoxicity. Role in β-cell adaptation and failure in the etiology of diabetes. Diabetes 2002; 51:405-13.
29. Biden TJ, Robinson D, Cordery D, Hughes W, Busch AK. Chronic effects of fatty acids on pancreatic β-cell function. New insights from functional genomics. Diabetes 2004; 53:159-65.
30. Patane G, Anello M, Piro S, Vigner R, Purello F, Rabuazzo AM. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisomal proliferators-activated receptor γ inhibition. Diabetes 2002; 51:2749-56.
31. Krauss S, Zhang CY, Scorrano L, Dalgaard LF, Pierre JS, Grey ST, et al. Superoxide-mediated activation of uncoupling protein 2 causes pancreatic β-cell dysfunction. J Clin Invest 2003; 112:1831-42. (Pubitemid 38063706)
32. Liang Y, Najafi H, Matschinsky FM. Glucose regulates glucokinase activity in cultured islets from rat pancreas. J Biol Chem 1990; 265:16863-6.
33. Trus MD, Zawalich WS, Burch PT, Berner DK, Weill VA, Matschinsky FM. Regulation of glucose metabolism in pancreatic islets. Diabetes 1981; 30:911-22.
34. Lowry H, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
35. Shao J, Qiao L, Friedman JE. Prolactin, progesterone and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6-β-cells. Am J Physiol Endocr Metab 2004; 286:304-10.
36. Welter HJ, McBain SC, Tadayyon M, Scarpello JHB, Smith SA, Morgan NG. Expression and functional activity of PPARγ in pancreatic β-cells. British J of Pharmacol 2004; 142:1162-70.
37. Lameloise N, Muzzin P, Prentki M, Assimacopoulos-Jeannet F. Uncoupling protein 2: A possible link between fatty acid excess and impaired glucose-induced insulin secretion. Diabetes 2001; 50:803-9.
38. Snedecor GWP, Cochran WG. Statistical methods. Ames (Iowa): Iowa University Press 1967; 339-50.